Integral Diagnostics Limited (ASX: IDX) refers to its market release on 10 November 2025 announcing the appointment of Jason Martinez as the Company’s new Managing Director (MD) and Chief Executive Officer (CEO). That release noted that Mr Martinez’s commencement date would subsequently be confirmed to the market.

IDX advises that Mr Martinez will commence in his role with IDX on 6 August 2026, following an extended garden leave period with his former employer.

Dr Ian Kadish will continue serving as MD and CEO until Mr Martinez commences to ensure a seamless leadership transition for IDX.